Experiments do not support a recent claim that glutamate formed from the amination of citric acid cycle derived α-ketoglutarate is a messenger in glucoseinduced insulin secretion (P. Maechler and C. Wollheim, Nature 402: 685-689, 1999). Glucose, leucine, succinic acid methyl ester and α-ketoisocaproic acid all markedly stimulate insulin release, but do not increase glutamate levels in pancreatic islets. Increasing the intracellular glutamate levels to 10 fold higher than basal levels by adding glutamine to islets does not stimulate insulin release. When leucine is applied to islets in addition to glutamine, insulin release is almost as high as with glucose alone. This is consistent with the known ability of leucine to allosterically activate glutamate deamination by glutamate dehydrogenase which can supply α-ketoglutarate to the citric acid cycle. Experiments with mitochondria from pancreatic islets suggest that flux through the glutamate dehydrogenase reaction is quiescent during glucose-induced insulin secretion. These experiments support the traditional idea that when insulin release is associated with flux through glutamate dehydrogenase, the flux is in the direction of α-ketoglutarate. 
Introduction
Recently Maechler and Wollheim (1) on the basis of intricate and broad based experiments proposed that glutamate generated from citric acid cycle-derived α-ketoglutarate is a messenger in glucose-induced insulin secretion. The glutamate effect was not robust and its demonstration seemed to require rather narrowly defined conditions. For example, dimethylglutamate, a glutamate precursor that is permeable to the plasma membrane, caused a leftward shift in the concentration dependency of found in many tissues (2) including the pancreatic islets used in our current study (see below) and in islets studied by others (3, 4) 1 . In addition, others have observed previously that glucose does not increase glutamate in islets (3 Metabolite measurements. Glutamate and α-ketoglutarate were measured by alkali-enhanced fluorescence (10, 11 stimulated by glucose alone (9) . Although the addition of glutamine alone to the incubation mixture has no effect on insulin release, when glutamine is added along with leucine, insulin release is increased to levels almost as high as with glucose (reference 9 and Table 1 ). Leucine did not increase, but lowered the level of glutamate derived from glutamine from ten fold higher than the basal level to six fold higher than the unstimulated level (Table 1 ). This may have been due to its augmenting the metabolism of glutamate (4-9) and / or inhibiting the conversion of glutamine to glutamate (4).
It was hypothesized that glutamate formed in the glutamate dehydrogenase reaction from the amination of α-ketoglutarate triggers insulin release by entering insulin secretory granules (1). However, much published evidence (4-9, 13) and evidence presented below suggest that when insulin release is associated with flux through glutamate dehydrogenase, flux is in the direction of α-ketoglutarate
and not in the direction of glutamate. Glucose stimulates insulin release by aerobic glycolysis. It is known that the beta cell possesses pyruvate carboxylase and that one half of glucose-derived pyruvate enters the citric acid cycle via carboxylation which can augment cycle intermediates by anaplerosis (10, (14) (15) (16) (17) . Surplus intermediates are exported from the mitochondria (10) . Data from experiments with isolated mitochondria from islets or INS-1 cells ( (Table 2) . When pyruvate and aspartate were added together, both glutamate and α-ketoglutarate export were increased. The increase in glutamate export could result from transamination of aspartate catalyzed by aspartate aminotransferase, while the increase in α-ketoglutarate could be because pyruvate increased the level of α-ketoglutarate through anaplerosis (10, 16) . Thus, since there was only significant export of glutamate from islet mitochondria when aspartate was added with either α-ketoglutarate or pyruvate and since pyruvate, succinate and α-ketoglutarate failed to promote significant export of glutamate, it seems unlikely that glutamate generated in beta cell mitochondria could be an intracellular messenger in glucose-induced insulin secretion. Glutamate can, however, become a metabolizable insulin secretagogue when its deamination is activated by leucine (4-9).
The idea that glutamate deamination catalyzed by glutamate dehydrogenase is a mechanism of insulin secretion in humans is suggested by the hypoglycemic disease hyperinsulinism/hyperammonemia syndrome. This disease is caused by various gain of function mutations in the glutamate dehydrogenase gene in exons encoding the binding site for GTP (18) an allosteric inhibitor of the enzyme (19, 20) . Since this results in the enzyme having a lower affinity for GTP, glutamate deamination catalyzed by the enzyme should be always activated. In the beta cell where the level of glutamate dehydrogenase is low, this would result in persistently enhanced insulin secretion and increased generation of ammonia by glutamate dehydrogenase. Excessive liver glutamate dehydrogenase activity may also explain the hyperammonemia (18) 2 .
It is interesting that not only is it unlikely that glutamate is involved in glucoseinduced insulin secretion, but also the activation processes of glucose-induced insulin release and glutamate metabolism-induced insulin release appear to be reciprocal to one another. Pancreatic islets maintained in a normal or a high concentration of glucose exhibit an intact response to glucose, but markedly decreased insulin release in response to leucine, while islets maintained in a low concentration of glucose show a normal or enhanced leucine response (13, 21, 22) and markedly diminished glucose response (21, 22) . It has been suggested that the low glucose effect may explain beta cell hypersensitivity to leucine frequently seen in hypoglycemic states (13) . The mechanism of glucose's suppression of leucineinduced insulin release has been suggested to be due to inhibition of glutamate deamination from increased levels of GTP and altered levels of other effectors of glutamate dehydrogenase resulting from glucose metabolism (13) .
Calculations with data from reference 1 and Table 1 
